Anti-tumor effects of paeonol in melanoma by up-regulating miR-143 and suppressing its target WNT5B

  • Meishan Piao Department of Dermatology, Wuxi No. 2 People’s Hospital, Wuxi, Jiangsu, China
  • Guangdong Feng Department of Dermatology, Wuxi No. 2 People’s Hospital, Wuxi, Jiangsu, China
Keywords: melanoma, paeonol, miR-143, WNT5B


Previous studies have shown the potent anti-tumor effect of paeonol, a natural compound extracted from traditional Chinese herb medicine. However, the therapeutic effect and underlying mechanisms of paeonol in melanoma are largely unknown. Two melanoma cell lines (M14 and A375) were cultured in the presence of paeonol. Cell proliferation was determined by colony formation and cell-counting kit 8 assays. Real-time quantitative reverse transcription polymerase chain reaction and Western blot were performed to detect mRNA and protein expression, respectively. Paeonol treatment significantly inhibited the colony formation and proliferation of melanoma cells by enhancing the expression of the well-characterized tumor suppressor microRNA (miR)-143. Block of miR-143 diminished the inhibitory effects of paeonol on cell growth. miR-143 directly bound to Wnt family member 5B (WNT5B) gene. Paeonol therefore down-regulated WNT5B expression through miR-143. Moreover, paeonol suppressed melanoma growth in vivo. Our study reveals that paeonol effectively suppresses melanoma cell growth both in vitro and in vivo through miR-143/WNT5B axis, which shows potential for the treatment of melanoma.


Download data is not yet available.


Johnson DB, Sosman JA. Therapeutic advances and treatment options in metastatic melanoma. JAMA Oncol 2015; 1(3): 380–6. doi: 10.1001/jamaoncol.2015.0565

Xu SP, Sun GP, Shen YX, Peng WR, Wang H, Wei W. Synergistic effect of combining paeonol and cisplatin on apoptotic induction of human hepatoma cell lines. Acta Pharmacol Sin 2007; 28(6): 869–78. doi: 10.1111/j.1745-7254.2007.00564.x

Del Prete SA, Maurer LH, O’Donnell J, Forcier RJ, LeMarbre P. Combination chemotherapy with cisplatin, carmustine, dacarbazine, and tamoxifen in metastatic melanoma. Cancer Treat Rep 1984; 68(11): 1403–5.

Lattanzi SC, Tosteson T, Chertoff J, Maurer LH, O’Donnell J, LeMarbre PJ, et al. Dacarbazine, cisplatin and carmustine, with or without tamoxifen, for metastatic melanoma: 5-year follow-up. Melanoma Res 1995; 5(5): 365–9. doi: 10.1097/00008390-199510000-00010

Chunhu Z, Suiyu H, Meiqun C, Guilin X, Yunhui L. Antiproliferative and apoptotic effects of paeonol on human hepatocellular carcinoma cells. Anticancer Drugs 2008; 19(4): 401–9. doi: 10.1097/CAD.0b013e3282f7f4eb

Li N, Fan LL, Sun GP, Wan XA, Wang ZG, Wu Q, et al. Paeonol inhibits tumor growth in gastric cancer in vitro and in vivo. World J Gastroenterol 2010; 16(35): 4483–90. doi: 10.3748/wjg.v16.i35.4483

Xing G, Zhang Z, Liu J, Hu H, Sugiura N. Antitumor effect of extracts from moutan cortex on DLD-1 human colon cancer cells in vitro. Mol Med Rep 2010; 3(1): 57–61. doi: 10.3892/mmr_00000218

Fan L, Song B, Sun G, Ma T, Zhong F, Wei W. Endoplasmic reticulum stress-induced resistance to doxorubicin is reversed by paeonol treatment in human hepatocellular carcinoma cells. PLoS One 2013; 8(5): e62627. doi: 10.1371/journal.pone.0062627

Yin J, Wu N, Zeng F, Cheng C, Kang K, Yang H. Paeonol induces apoptosis in human ovarian cancer cells. Acta Histochem 2013; 115(8): 835–9. doi: 10.1016/j.acthis.2013.04.004

Ou Y, Li Q, Wang J, Li K, Zhou S. Antitumor and apoptosis induction effects of paeonol on mice bearing EMT6 breast carcinoma. Biomol Ther 2014; 22(4): 341–6. doi: 10.4062/biomolther.2013.106

Zhang L, Tao L, Shi T, Zhang F, Sheng X, Cao Y, et al. Paeonol inhibits B16F10 melanoma metastasis in vitro and in vivo via disrupting proinflammatory cytokines-mediated NF-kappaB and STAT3 pathways. IUBMB Life 2015; 67(10): 778–88. doi: 10.1002/iub.1435

Li R, Zhang L, Jia L, Duan Y, Li Y, Wang J, et al. MicroRNA-143 targets Syndecan-1 to repress cell growth in melanoma. PLoS One 2014; 9(4): e94855. doi: 10.1371/journal.pone.0094855

Noguchi S, Mori T, Hoshino Y, Maruo K, Yamada N, Kitade Y, et al. MicroRNA-143 functions as a tumor suppressor in human bladder cancer T24 cells. Cancer Lett 2011; 307(2): 211–20. doi: 10.1016/j.canlet.2011.04.005

Zhang Y, Wang Z, Chen M, Peng L, Wang X, Ma Q, et al. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer. Mol Cancer 2012; 11: 23. doi: 10.1186/1476-4598-11-23

Ma Q, Jiang Q, Pu Q, Zhang X, Yang W, Wang Y, et al. MicroRNA-143 inhibits migration and invasion of human non-small-cell lung cancer and its relative mechanism. Int J Biol Sci 2013; 9(7): 680–92. doi: 10.7150/ijbs.6623

Shibahara S, Takeda K, Yasumoto K, Udono T, Watanabe K, Saito H, et al. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation. J Investig Dermatol Symp Proc 2001; 6(1): 99–104. doi: 10.1046/j.0022-202x.2001.00010.x

Dissanayake SK, Olkhanud PB, O’Connell MP, Carter A, French AD, Camilli TC, et al. Wnt5A regulates expression of tumor-associated antigens in melanoma via changes in signal transducers and activators of transcription 3 phosphorylation. Cancer Res 2008; 68(24): 10205–14. doi: 10.1158/0008-5472.CAN-08-2149

Weeraratna AT, Jiang Y, Hostetter G, Rosenblatt K, Duray P, Bittner M, et al. Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 2002; 1(3): 279–88. doi: 10.1016/S1535-6108(02)00045-4

He Z, Yi J, Liu X, Chen J, Han S, Jin L, et al. MiR-143-3p functions as a tumor suppressor by regulating cell proliferation, invasion and epithelial-mesenchymal transition by targeting QKI-5 in esophageal squamous cell carcinoma. Mol Cancer 2016; 15(1): 51. doi: 10.1186/s12943-016-0533-3

Almeida MI, Calin GA. The miR-143/miR-145 cluster and the tumor microenvironment: unexpected roles. Genome Med 2016; 8(1): 29. doi: 10.1186/s13073-016-0284-1

Li M, Tan SY, Wang XF. Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE(2) synthesis and COX-2 expression. Oncol Rep 2014; 32(6): 2845–53. doi: 10.3892/or.2014.3543

Zhang W, Cai J, Chen S, Zheng X, Hu S, Dong W, et al. Paclitaxel resistance in MCF-7/PTX cells is reversed by paeonol through suppression of the SET/phosphatidylinositol 3-kinase/Akt pathway. Mol Med Rep 2015; 12(1): 1506–14. doi: 10.3892/mmr.2015.3468

Dimitrova N, Gocheva V, Bhutkar A, Resnick R, Jong RM, Miller KM, et al. Stromal expression of miR-143/145 promotes neoangiogenesis in lung cancer development. Cancer Discov 2016; 6(2): 188–201. doi: 10.1158/2159-8290.CD-15-0854

Bhatia S, Tykodi SS, Thompson JA. Treatment of metastatic melanoma: an overview. Oncology 2009; 23(6): 488–96.

Chou TC. Anti-inflammatory and analgesic effects of paeonol in carrageenan-evoked thermal hyperalgesia. Br J Pharmacol 2003; 139(6): 1146–52. doi: 10.1038/sj.bjp.0705360

Ding Y, Li Q, Xu Y, Chen Y, Deng Y, Zhi F, et al. Attenuating oxidative stress by paeonol protected against acetaminophen-induced hepatotoxicity in mice. PLoS One 2016; 11(5): e0154375. doi: 10.1371/journal.pone.0154375

How to Cite
PiaoM., & FengG. (2023). Anti-tumor effects of paeonol in melanoma by up-regulating miR-143 and suppressing its target WNT5B. STEMedicine, 4(1), e161.
Research articles